Search

Search Results for “Pfizer”

Showing results 1 - 10 of 10

• Depo-Provera Lawsuits Say U.S. Label Lacks Tumor ...

  https://www.drugwatch.com/news/2024/11/08/depo-provera-lawsuits-say-u-s-label-lacks-tumor-warnings-that-are-included-overseas/
  Depo-Provera litigation over claims that it is linked to tumor development has begun to pick up, with multiple lawsuits now filed.

• Big Pharma Paid $3.5 Billion to Doctors, Hospitals in 2013

  https://www.drugwatch.com/news/2014/10/02/big-pharma-pay-doctors-hospitals-billions/
  The feds forced Big Pharma's top players including Eli Lily, Pfizer and GlaxoSmithKline (GSK) to report all their gifts to health care providers

• Lawyers Accepting Benzocaine Methemoglobinemia ...

  https://www.drugwatch.com/news/2018/07/24/lawyers-accepting-benzocaine-methemoglobinemia-lawsuits/
  Some store brand-name products contain benzocaine. Benzocaine products and manufacturers include: Anbesol — Pfizer; Cepacol lozenges — Reckitt ...

• FDA Reconsiders, Orders Heart Attack Warning for ...

  https://www.drugwatch.com/news/2015/03/05/fda-orders-testosterone-heart-attack-warning/
  The FDA warned that testosterone therapy drugs are over prescribed and overused and may increase the risk of heart attack, stroke and other ...

• First Zantac Lawsuit Case Reaches $500000 Settlement

  https://www.drugwatch.com/news/2022/08/30/first-zantac-cancer-case-settlement/
  Joseph Bayer voluntarily dropped his Zantac lawsuit against GlaxoSmithKline after settling with generic drugmakers.

• What's New in Dangerous Product Lawsuits Heading Into ...

  https://www.drugwatch.com/news/2025/08/05/whats-new-in-dangerous-product-lawsuits-heading-into-august-2025/
  Pfizer Ignored Depo-Provera Brain Tumor Risks for Decades, Plaintiffs Claim September 25, 2025

• Breaking News: Takeda Settles Actos Lawsuits for $2.37 ...

  https://www.drugwatch.com/news/2015/04/29/takeda-actos-settlement-2-billion/
  The Japanese drug company agreed to pay $2.37 billion to plaintiffs who claimed the company's blockbuster Type 2 diabetes drug, Actos (pioglitazone), gave them ...

• Cancer & COVID-19 Risk: A Q&A with Dr. Gary Lyman

  https://www.drugwatch.com/news/2021/02/08/cancer-covid-19-risk-qa-dr-gary-lyman/
  The Pfizer study allowed patients with a history of cancer who were recovered but they constituted only about three percent of the total.

• FDA Delays Action on Bleeding Remedy for Xarelto, Eliquis

  https://www.drugwatch.com/news/2018/01/19/fda-delays-action-on-bleeding-remedy-for-xarelto-eliquis/
  The FDA says it will wait until May 2018 to announce its decision on an application for AndrexXa, an antidote to uncontrolled bleeding in ...

• Boehringer Ingelheim to Settle 4000 Pradaxa Lawsuits for ...

  https://www.drugwatch.com/news/2014/05/28/boehringer-ingelheim-settles-pradaxa-lawsuits/
  German manufacturer Boehringer Ingelheim announced today that it will pay $650 million to settle all 4,000 state and federal lawsuits over ...